Cargando…

SARS-CoV2 wild type and mutant specific humoral and T cell immunity is superior after vaccination than after natural infection

OBJECTIVE: We investigated blood samples from fully SARS-CoV2-vaccinated subjects and from previously positive tested patients up to one year after infection with SARS-CoV2, and compared short- and long-term T cell and antibody responses, with a special focus on the recently emerged delta variant (B...

Descripción completa

Detalles Bibliográficos
Autores principales:	Richardson, Jennifer R., Götz, Ralph, Mayr, Vanessa, Lohse, Martin J., Holthoff, Hans-Peter, Ungerer, Martin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9037910/ https://www.ncbi.nlm.nih.gov/pubmed/35468147 http://dx.doi.org/10.1371/journal.pone.0266701

Ejemplares similares

Review of Mouse Models of Graves’ Disease and Orbitopathy—Novel Treatment by Induction of Tolerance
por: Ungerer, Martin, et al.
Publicado: (2016)

Cyclopeptide COR-1 to treat beta1-adrenergic receptor antibody-induced heart failure
por: Boivin-Jahns, Valérie, et al.
Publicado: (2018)

Overexpression of ABCG1 protein attenuates arteriosclerosis and endothelial dysfunction in atherosclerotic rabbits
por: Münch, Götz, et al.
Publicado: (2012)

The GPVI – Fc Fusion Protein Revacept Reduces Thrombus Formation and Improves Vascular Dysfunction in Atherosclerosis without Any Impact on Bleeding Times
por: Ungerer, Martin, et al.
Publicado: (2013)

Combined administration of the GPVI-Fc fusion protein Revacept with low-dose thrombolysis in the treatment of stroke
por: Reimann, Andreas, et al.
Publicado: (2016)

Automated detection of neutralizing SARS-CoV-2 antibodies in minutes using a competitive chemiluminescence immunoassay
por: Klüpfel, Julia, et al.
Publicado: (2022)

The GPVI-Fc Fusion Protein Revacept Improves Cerebral Infarct Volume and Functional Outcome in Stroke
por: Goebel, Silvia, et al.
Publicado: (2013)

A fructosylated peptide derived from a collagen II T cell epitope for long-term treatment of arthritis (FIA-CIA) in mice
por: Wenhart, Clara, et al.
Publicado: (2021)

Tissue block staining and domestic adhesive tape yield qualified integral sections of adult mouse orbits and eyeballs
por: Li, Zhongmin, et al.
Publicado: (2021)

Natural humoral immunity per year after SARS-CoV-2 infection in hospitalized patients()
por: Cabanes, Luis, et al.
Publicado: (2022)

Population-based study of the durability of humoral immunity after SARS-CoV-2 infection
por: Peterhoff, David, et al.
Publicado: (2023)

Dextransucrase from the mutant of Pediococcus pentosaceus (PPm) is more stable than the wild type
por: Kothari, Damini, et al.
Publicado: (2011)

Function Is More Reliable Than Quantity to Follow Up the Humoral Response to the Receptor-Binding Domain of SARS-CoV-2-Spike Protein after Natural Infection or COVID-19 Vaccination
por: Sariol, Carlos A., et al.
Publicado: (2021)

Function is more reliable than quantity to follow up the humoral response to the Receptor Binding Domain of SARS- CoV-2 Spike protein after natural infection or COVID-19 vaccination
por: Sariol, Carlos A., et al.
Publicado: (2021)

SARS-CoV-2 infection severity is linked to superior humoral immunity against the spike
por: Guthmiller, Jenna J., et al.
Publicado: (2020)

SARS-CoV-2 Infection Severity Is Linked to Superior Humoral Immunity against the Spike
por: Guthmiller, Jenna J., et al.
Publicado: (2021)

MULTIDIMENSIONAL FRAILTY SCORE IS SUPERIOR TO PREDICT COMPLICATIONS AFTER SURGERY THAN CONVENTIONAL RISK FACTORS
por: Choi, Jung-Yeon, et al.
Publicado: (2019)

Longitudinal dynamics of SARS-CoV-2-specific cellular and humoral immunity after natural infection or BNT162b2 vaccination
por: Almendro-Vázquez, Patricia, et al.
Publicado: (2021)

Are natural killer cells superior CAR drivers?
por: Klingemann, Hans
Publicado: (2014)

Superior Intrinsic Mitochondrial Respiration in Women Than in Men
por: Cardinale, Daniele A., et al.
Publicado: (2018)

30 Days Wild: Development and Evaluation of a Large-Scale Nature Engagement Campaign to Improve Well-Being
por: Richardson, Miles, et al.
Publicado: (2016)

Flow Dynamics of Bilateral Superior Cavopulomonary Shunts Influence Outcomes After Fontan Completion
por: Ono, Masamichi, et al.
Publicado: (2020)

Genomic abundance and transcriptional activity of diverse gypsy and copia long terminal repeat retrotransposons in three wild sunflower species
por: Qiu, Fan, et al.
Publicado: (2018)

Dynamics of humoral and T-cell immunity after three BNT162b2 vaccinations in adults older than 80 years
por: Romero-Olmedo, Addi J, et al.
Publicado: (2022)

Superior humoral immunity in vaccinated SARS-CoV-2 convalescence as compared to SARS-COV-2 infection or vaccination
por: Paniskaki, Krystallenia, et al.
Publicado: (2022)

Cellular and humoral immunity in a wild mammal: Variation with age & sex and association with overwinter survival
por: Watson, Rebecca L., et al.
Publicado: (2016)

Oxaliplatin-Based Chemotherapy Is More Beneficial in KRAS Mutant than in KRAS Wild-Type Metastatic Colorectal Cancer Patients
por: Lin, Yu-Lin, et al.
Publicado: (2014)

30 Days Wild and the Relationships Between Engagement With Nature’s Beauty, Nature Connectedness and Well-Being
por: Richardson, Miles, et al.
Publicado: (2018)

SARS-CoV2-specific Humoral and T-cell Immune Response After Second Vaccination in Liver Cirrhosis and Transplant Patients
por: Ruether, Darius F., et al.
Publicado: (2022)

Humoral and cellular responses after COVID-19 vaccination in anti-CD20-treated lymphoma patients
por: Liebers, Nora, et al.
Publicado: (2022)

Mobility and subcellular localization of endogenous, gene-edited Tau differs from that of over-expressed human wild-type and P301L mutant Tau
por: Di Xia,, et al.
Publicado: (2016)

Natural and Induced Humoral Responses to MUC1
por: von Mensdorff-Pouilly, Silvia, et al.
Publicado: (2011)

Humoral immune response after different SARS-CoV-2 vaccination regimens
por: Rose, Ruben, et al.
Publicado: (2022)

Humoral Response after SARS-CoV-2 Vaccination in Prostate Cancer Patients
por: Błaszczuk, Agata, et al.
Publicado: (2023)

Serological Humoral Immunity Following Natural Infection of Children with High Burden Gastrointestinal Viruses
por: Zweigart, Mark R., et al.
Publicado: (2021)

Humoral and Cellular Immune Response After Third and Fourth SARS-CoV-2 mRNA Vaccination in Liver Transplant Recipients
por: Harberts, Aenne, et al.
Publicado: (2022)

Cancer: From Wild-Type to Mutant Huntingtin
por: Thion, Morgane Sonia, et al.
Publicado: (2018)

Humoral and cellular immunity after vaccination against SARS-CoV-2 is reduced in patients with chronic liver disease
por: Samer, Al-Dury, et al.
Publicado: (2022)

Strong Cellular Immune Response, but Not Humoral, against SARS-CoV-2 in Oncohematological Patients with Autologous Stem Cell Transplantation after Natural Infection
por: Vigón, Lorena, et al.
Publicado: (2022)

SARS-CoV2 mRNA Vaccine-Specific B-, T- and Humoral Responses in Adolescents After Kidney Transplantation
por: Sattler, Arne, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1jdqm64gi0kfhh0nvp9tbae02v